| Product Code: ETC10797345 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Pharmacogenomics Technology Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Pharmacogenomics Technology Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Pharmacogenomics Technology Market - Industry Life Cycle |
3.4 Serbia Pharmacogenomics Technology Market - Porter's Five Forces |
3.5 Serbia Pharmacogenomics Technology Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.6 Serbia Pharmacogenomics Technology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Serbia Pharmacogenomics Technology Market Revenues & Volume Share, By Testing Method, 2021 & 2031F |
3.8 Serbia Pharmacogenomics Technology Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Serbia Pharmacogenomics Technology Market Revenues & Volume Share, By Market Driver, 2021 & 2031F |
3.9.1 Increasing demand for personalized medicine |
3.9.2 Growing prevalence of chronic diseases in Serbia |
3.9.3 Technological advancements in pharmacogenomics |
4 Serbia Pharmacogenomics Technology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
4.3.1 Limited awareness among healthcare providers and patients about pharmacogenomics |
4.3.2 High cost associated with pharmacogenomic testing and technology implementation |
5 Serbia Pharmacogenomics Technology Market Trends |
6 Serbia Pharmacogenomics Technology Market, By Types |
6.1 Serbia Pharmacogenomics Technology Market, By Technology Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Technology Type, 2021 - 2031F |
6.1.3 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Genotyping, 2021 - 2031F |
6.1.4 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Next-Generation Sequencing, 2021 - 2031F |
6.1.5 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Gene Expression Profiling, 2021 - 2031F |
6.1.6 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Bioinformatics Solutions, 2021 - 2031F |
6.1.7 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Companion Diagnostics, 2021 - 2031F |
6.2 Serbia Pharmacogenomics Technology Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.2.3 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Drug Response Analysis, 2021 - 2031F |
6.2.4 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Oncology Treatment, 2021 - 2031F |
6.2.5 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Adverse Drug Reactions, 2021 - 2031F |
6.2.6 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Clinical Trials, 2021 - 2031F |
6.3 Serbia Pharmacogenomics Technology Market, By Testing Method |
6.3.1 Overview and Analysis |
6.3.2 Serbia Pharmacogenomics Technology Market Revenues & Volume, By PCR-Based, 2021 - 2031F |
6.3.3 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Microarray, 2021 - 2031F |
6.3.4 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Whole Genome Sequencing, 2021 - 2031F |
6.3.5 Serbia Pharmacogenomics Technology Market Revenues & Volume, By AI-Based Analytics, 2021 - 2031F |
6.3.6 Serbia Pharmacogenomics Technology Market Revenues & Volume, By DNA Microarray, 2021 - 2031F |
6.4 Serbia Pharmacogenomics Technology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Pharma Companies, 2021 - 2031F |
6.4.3 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.4 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Research Labs, 2021 - 2031F |
6.4.5 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Academic Institutions, 2021 - 2031F |
6.4.6 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Diagnostic Centers, 2021 - 2031F |
6.5 Serbia Pharmacogenomics Technology Market, By Market Driver |
6.5.1 Overview and Analysis |
6.5.2 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Advancements in Precision Medicine, 2021 - 2031F |
6.5.3 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Increase in Genetic Testing, 2021 - 2031F |
6.5.4 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Growing Interest in Targeted Therapy, 2021 - 2031F |
6.5.5 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Expansion in Pharmacovigilance, 2021 - 2031F |
6.5.6 Serbia Pharmacogenomics Technology Market Revenues & Volume, By Demand for Tailored Therapeutics, 2021 - 2031F |
7 Serbia Pharmacogenomics Technology Market Import-Export Trade Statistics |
7.1 Serbia Pharmacogenomics Technology Market Export to Major Countries |
7.2 Serbia Pharmacogenomics Technology Market Imports from Major Countries |
8 Serbia Pharmacogenomics Technology Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenomic testing |
8.2 Adoption rate of pharmacogenomics technology among healthcare providers |
8.3 Number of research studies and publications on pharmacogenomics in Serbia |
9 Serbia Pharmacogenomics Technology Market - Opportunity Assessment |
9.1 Serbia Pharmacogenomics Technology Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.2 Serbia Pharmacogenomics Technology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Serbia Pharmacogenomics Technology Market Opportunity Assessment, By Testing Method, 2021 & 2031F |
9.4 Serbia Pharmacogenomics Technology Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Serbia Pharmacogenomics Technology Market Opportunity Assessment, By Market Driver, 2021 & 2031F |
10 Serbia Pharmacogenomics Technology Market - Competitive Landscape |
10.1 Serbia Pharmacogenomics Technology Market Revenue Share, By Companies, 2024 |
10.2 Serbia Pharmacogenomics Technology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here